I don't know much about the Stock, other than they front the Cash for Crisper Therapeutics (CRSP).
I like the chart. Looks fundamentally cheap. Trading @ 15.5 next years earnings, with 10% revenue growth forecast. Lots of cash, low debt. Price seems to be out of sync with the broad market.
@Sol, how does this look with your proprietary indicators?
On the monthly charts it is trading in almost the insanely oversold ranges, MACD's are close to experiencing a bullish crossover. Overall it looks interesting. The outlook will remain bullish as long as it does not close below 177 on a monthly basis.
When the words short term appear under any post; the same conditions listed in the Market update under the short term category apply
The end is always near; its the beginning and how you live each moment that counts the most
SOL wrote: ↑Sun Dec 05, 2021 7:28 pm
On the monthly charts it is trading in almost the insanely oversold ranges, MACD's are close to experiencing a bullish crossover. Overall it looks interesting. The outlook will remain bullish as long as it does not close below 177 on a monthly basis.
Thanks, Sol. Always good to have a secondary opinion when treading in less familiar territory. In this case, Biotech.
@Jaz: hey, I found a girl for you - her name is Sophia. She may be almost as smart as you. At approximately the 10-minute mark of the clip, she gives her thoughts on cryptos in general and Cardano in particular. She also opines about the future of human lifeforms in the last three minutes of the clip:
